SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle.
Format / Length
an2
Description
Permitted Codes
| Code | Description | 
|---|---|
| 
   01  | 
        
   Intravenous  | 
      
| 
   02  | 
        
   Oral  | 
      
| 
   03  | 
        
   Intrathecal  | 
      
| 
   04  | 
        
   Intramuscular  | 
      
| 
   05  | 
        
   Subcutaneous  | 
      
| 
   06  | 
        
   Intraarterial  | 
      
| 
   07  | 
        
   Intraperitoneal  | 
      
| 
   08  | 
        
   Other intracavity Intracavernous  | 
      
| 
   09  | 
        
   Intravesical (Intra-Vesicular)  | 
      
| 
   10  | 
        
   Intratumour / Intralesional (Retired 1 September 2019 )  | 
      
| 
   11  | 
        
   Cutaneous (Topical)  | 
      
| 
   12  | 
        
   Intradermal  | 
      
| 
   13  | 
        
   Intratumour  | 
      
| 
   14  | 
        
   Intralesional  | 
      
| 
   99  | 
        
   Other (Retired 1 September 2019 )  | 
      
| 
   98  | 
        
   Other (not listed)  | 
      
Also Known As
This data element is also known by these names:
| Context | Alias | 
|---|---|
| Plural | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTES OF ADMINISTRATION | 
Where Used
| Type | Link | How used | 
|---|---|---|
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | 
| Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |